Literature DB >> 22497951

Computed tomography with histological correlation for evaluating tumor regression of rectal carcinoma after preoperative chemoradiation therapy.

Chung-Ta Lee1, Nan-Haw Chow, Yi-Sheng Liu, Shao-Chieh Lin, Peng-Chan Lin, Yuan-Hua Wu, Jenq-Chang Lee, Hong-Ming Tsai.   

Abstract

BACKGROUND/AIMS: Preoperative chemoradiation therapy (CRT) is standard procedure for locally advanced rectal cancer. The correlation of tumor response evaluated using CT according to response evaluation criteria in solid tumors (RECIST) with the histo-logical tumor regression grade (TRG) is not well-documented.
METHODOLOGY: Ninety-one patients with rectal cancer underwent CT examinations before and after preoperative CRT and following surgery. Clinical tumor staging and tumor response assessed according to RECIST were done on paired CT scans. Pathological tumor staging and TRGs were reviewed in resected specimens.Post-CRT CT findings and histological findings were compared. Survival analysis for 73 patients was done.
RESULTS: TRG was positively correlated with the CT-assessed tumor response (r=0.276, p=0.009). Thickened fibrotic areas and muscle disarray caused by fibrosis were more frequently seen in cases of patients over-diagnosed as having residual tumors. The ycT status was positively correlated with ypT status (r=0.44, p<0.001;accuracy=61.5%). Downstaging of cT status was cor-related with a lower TRG (p=0.001).
CONCLUSIONS: Fibrosis emerges after neoadjuvant therapy and is usual-ly accompanied by tumor reduction on CT scans of rec-tal cancer patients following preoperative CRT. There-fore, tumor response assessed using CT according to RECIST may serve as a supplementary tool for preoperative planning other than tumor restaging.

Entities:  

Mesh:

Year:  2012        PMID: 22497951     DOI: 10.5754/hge12165

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

Review 1.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?

Authors:  Paola De Nardi; Michele Carvello
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  Chemoradiotherapy response in recurrent rectal cancer.

Authors:  Stanley K T Yu; Aneel Bhangu; Diana M Tait; Paris Tekkis; Andrew Wotherspoon; Gina Brown
Journal:  Cancer Med       Date:  2013-12-16       Impact factor: 4.452

Review 4.  Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy.

Authors:  Jian Cui; Hui Fang; Lin Zhang; Yun-Long Wu; Hai-Zeng Zhang
Journal:  Chronic Dis Transl Med       Date:  2016-07-28

5.  Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer.

Authors:  Zhenghao Cai; Weiwei Rui; Shuchun Li; Abraham Fingerhut; Jing Sun; Junjun Ma; Lu Zang; Zhenggang Zhu; Minhua Zheng
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.